Canadian Medical Marijuana Firm Aurora Cannabis Expects Weak Demand In International Market
1. Aurora reported a loss of 24 cents per share, missing estimates. 2. Sales reached $63.07 million, above the consensus of $62.04 million. 3. Medical cannabis revenue rose 48% year over year, dominating total revenue. 4. Consumer cannabis revenue declined 20% year over year due to strategic focus. 5. Aurora expects stable future performance with strong international medical sales.